A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors

NCT04158583 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
76
Enrollment
INDUSTRY
Sponsor class

Stopped Halted in order to focus on the ongoing combination of RO7296682 with Atezolizumab, evaluated in study BP42595, as a higher likelihood for efficacy is expected in combination with Atezolizumab as compared to the monotherapy setting.

Conditions

Interventions

Sponsor

Hoffmann-La Roche